http://www.tymeinc.com http://www.tymeinc.com/about-tyme/leadership/default.html http://www.tymeinc.com/about-tyme/board-of-directors/default.html http://www.tymeinc.com/about-tyme/medical-advisory-board/default.html http://www.tymeinc.com/our-science/sm-88-overview/default.html http://www.tymeinc.com/our-science/tyme-18-overview/default.html http://www.tymeinc.com/our-science/tyme-19-overview/default.html http://www.tymeinc.com/our-science/scientific-references/default.html http://www.tymeinc.com/tyme-trials/default.html http://www.tymeinc.com/tyme-trials/faq/default.html http://www.tymeinc.com/tyme-trials/patient-support/default.html http://www.tymeinc.com/data-publications/scientific-presentations/default.html http://www.tymeinc.com/data-publications/publications/default.html http://www.tymeinc.com/newsroom/default.html http://www.tymeinc.com/investors/contact/default.html http://www.tymeinc.com/investors/investor-overview/default.html http://www.tymeinc.com/investors/press-releases/default.html http://www.tymeinc.com/investors/events-and-presentations/default.html http://www.tymeinc.com/investors/stock-info/default.html http://www.tymeinc.com/investors/financials/default.html http://www.tymeinc.com/investors/governance/default.html http://www.tymeinc.com/about-tyme/tyme-overview/default.html http://www.tymeinc.com/our-science/mechanism-of-action/default.html http://www.tymeinc.com/our-science/pipeline/default.html http://www.tymeinc.com/newsroom/press-releases/default.html http://www.tymeinc.com/privacy-policy-and-terms/default.html http://www.tymeinc.com/pipeline/sm-88-overview/default.html http://www.tymeinc.com/home/default.html http://www.tymeinc.com/investors/contact/email-alerts/default.html http://www.tymeinc.com/investors/events-and-presentations/events/default_ShowEvents-FUTURE.html http://www.tymeinc.com/investors/events-and-presentations/events/default_ShowEvents-PAST.html http://www.tymeinc.com/gclid-EAIaIQobChMIkf-wsJ3J7gIVgYfICh2HtwgVEAAYASAAEgLyPPD_BwE.html http://www.tymeinc.com/justsaying-1.html http://www.tymeinc.com/justsaying-1/favicon.html http://www.tymeinc.com/justsaying-1/robots.html http://www.tymeinc.com/about-tyme/board-of-directors.html http://www.tymeinc.com/about-tyme/leadership.html http://www.tymeinc.com/about-tyme/management/default.html http://www.tymeinc.com/about-tyme/media/default.html http://www.tymeinc.com/about-tyme/medical-advisory-board.html http://www.tymeinc.com/about-tyme/tyme-overview.html http://www.tymeinc.com/boardofdirectors.html http://www.tymeinc.com/Clinical-Trial-Popup-Iframe.html http://www.tymeinc.com/clinical-trials.html http://www.tymeinc.com/clinical-trials/Compassionate-Use/default.html http://www.tymeinc.com/clinical-trials/phase-ib-ii-prostate-cancer-study/default.html http://www.tymeinc.com/clinical-trials/phase-ii-pancreatic-cancer-study/default.html http://www.tymeinc.com/codeofethics.html http://www.tymeinc.com/data-publications/publications.html http://www.tymeinc.com/data-publications/scientific-presentations.html http://www.tymeinc.com/emailsigs/hoffman.html http://www.tymeinc.com/events.html http://www.tymeinc.com/home.html http://www.tymeinc.com/Home/About.html http://www.tymeinc.com/Home/Board_Of_Directors.html http://www.tymeinc.com/Home/Contact.html http://www.tymeinc.com/home/default_id-925.html http://www.tymeinc.com/home/default_id-925-platform-GoogleCalendar.html http://www.tymeinc.com/home/default_id-933.html http://www.tymeinc.com/home/default_id-933-platform-GoogleCalendar.html http://www.tymeinc.com/home/default_id-{{id}}.html http://www.tymeinc.com/home/default_id-{{id}}-platform-GoogleCalendar.html http://www.tymeinc.com/home/default_version-5_4_5.html http://www.tymeinc.com/Home/Executives.html http://www.tymeinc.com/Home/Index.html http://www.tymeinc.com/Home/Investor_Relations.html http://www.tymeinc.com/Home/Medical_Advisory_Board.html http://www.tymeinc.com/Home/Privacy_And_Terms.html http://www.tymeinc.com/Home/SM88.html http://www.tymeinc.com/investors/contact.html http://www.tymeinc.com/investors/contact/email-alerts.html http://www.tymeinc.com/investors/events-and-presentations.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2019/2019-Cross-Border-Healthcare-Winter-Summit/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2020/2020-ASCO-Gastrointestinal-Cancers-Symposium/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2020/Canaccord-Virtual-40th-Annual-Growth-Conference-/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2020/Oppenheimer-Fall-Healthcare-Life-Sciences--MedTech-Summit/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2020/Virtual-2020-Annual-Meeting-of-Stockholders/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2021/2021-Cantor-Virtual-Global-Healthcare-Conference/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2021/Q4-Fiscal-2021-Investor-Conference-Call/default.html http://www.tymeinc.com/investors/events-and-presentations/events/event-details/2022/ASCO-2022-Gastrointestinal-Cancers-Symposium/default.html http://www.tymeinc.com/investors/financials.html http://www.tymeinc.com/investors/financials/sec-filings/sec-filings-details/default.html http://www.tymeinc.com/investors/financials/sec-filings/sec-filings-details/default_FilingId-14845030.html http://www.tymeinc.com/investors/governance.html http://www.tymeinc.com/investors/investor-overview.html http://www.tymeinc.com/investors/news-releases/default.html http://www.tymeinc.com/files/default_nda6jwrwk5eqiif38mr3si.html http://www.tymeinc.com/investors/press-releases.html http://www.tymeinc.com/investors/press-releases/press-release-details/2018/Tyme-Appoints-Pharma-Executive-Don-DeGolyer-to-Board-of-Directors/default.html http://www.tymeinc.com/files/default_2xnv46hfv0pnw2dp6h8th2.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/TYME-18-Demonstrates-Anti-Cancer-Effect-in-New-Preclinical-Data-Presented-at-AACR-2020/default.html http://www.tymeinc.com/files/default_x6cdioyncd4kr2txua3e0y.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/TYME-Announces-Orphan-Drug-Designation-for-SM-88-as-Potential-Treatment-for-Patients-with-Pancreatic-Cancer/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/TYME-Announces-Outcome-of-Interim-Futility-Review-for-HopES-Sarcoma-Phase-II-Study/default.html http://www.tymeinc.com/files/default_2fwbmhbdgnnajc5o536uhz.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/TYME-Presents-New-Preclinical-Data-Supporting-SM-88-Mechanism-of-Action-at-AACR-2020/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/TYME-Provides-Business-Update-and-Announces-Preliminary-First-Quarter-Fiscal-2021-Financial-and-Operating-Results/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/TYME-Provides-Business-Update-and-Announces-Second-Quarter-Fiscal-2021-Financial-and-Operating-Results/default.html http://www.tymeinc.com/files/default_ehppp5py67nbjtdhiqrvxi.html http://www.tymeinc.com/investors/press-releases/press-release-details/2020/Tyme-Technologies-Announces-Virtual-2020-Annual-Meeting-of-Stockholders/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Announces-Abstract-Selected-for-Publication-at-the-2021-American-Society-of-Clinical-Oncology-Annual-Meeting/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Announces-Closing-of-100-Million-Registered-Direct-Offering-of-Common-Stock/default.html http://www.tymeinc.com/files/th-a-CDK46-Inhibitor_i2jz543kgc50tgeyu64eyr.html http://www.tymeinc.com/files/default_b8u80vktw3jasmbe53e5cb.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Appoints-Frank-L.-Porfido-as-Chief-Financial-Officer/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Granted-U.S.-Patent-Claims-Covering-Use-of-TYME-19-to-Treat-COVID-19-Infections/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/Tyme-Granted-U.S.-Patent-Claims-Covering-Use-of-Tyrosine-Based-Drug-Delivery-Method-to-Treat-Cancer/default.html http://www.tymeinc.com/files/default_zysk8ggqz7wieuqs4h7sia.html http://www.tymeinc.com/files/default_3u2w7ky5fpiokop8sy5asn.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Technologies-Inc.-Provides-Business-Update-and-Announces-Fiscal-First-Quarter-2022-Financial-and-Operating-Results.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Technologies-Inc.-to-Host-Conference-Call-and-Live-Video-Webcast-on-Thursday-June-10th-at-500-PM-ET/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Technologies-Inc.-to-Host-Conference-Call-and-Webcast-on-Monday-November-8th-at-830-AM-ET.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Technologies-Inc.-to-Present-at-Jefferies-London-Healthcare-Conference.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Technologies-Inc.-to-Present-at-Upcoming-Virtual-Healthcare-Industry-Conferences.html http://www.tymeinc.com/investors/press-releases/press-release-details/2021/TYME-Technologies-Inc.-to-Present-at-Upcoming-Virtual-Healthcare-Industry-Conferences/default.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/Syros-and-Tyme-Technologies-Announce-Stockholder-Approval-of-Merger.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/Syros-to-Raise-Approximately-190-Million-Through-Merger-with-TYME-Technologies-and-Concurrent-Private-Placement.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/TYME-Technologies-Inc.-Announces-Changes-to-its-Board-of-Directors.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/TYME-Technologies-Inc.-Announces-Exploration-of-Strategic-Options.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/TYME-Technologies-Inc.-Announces-Exploration-of-Strategic-Options/default.html http://www.tymeinc.com/files/er-of-Syros-and-Tyme_7suoxxnnivw4jjdve2u8zu.html http://www.tymeinc.com/files/default_dzg0s8pqv26pdoxxpc75zh.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/TYME-Technologies-Inc.-Reports-Fourth-Fiscal-Quarter-and-Full-Year-2022-Financial-and-Operating-Results.html http://www.tymeinc.com/investors/press-releases/press-release-details/2022/TYME-Technologies-Inc.-to-Present-at-H.C.-Wainwright-Bioconnect-Virtual-Conference/default.html http://www.tymeinc.com/investors/stock-info.html http://www.tymeinc.com/medicaladvisoryboard.html http://www.tymeinc.com/News.html http://www.tymeinc.com/News/Cancer_Moonshot_within_grasp.html http://www.tymeinc.com/News/Resilience.html http://www.tymeinc.com/newsroom.html http://www.tymeinc.com/newsroom/media-library/default.html http://www.tymeinc.com/newsroom/press-releases.html http://www.tymeinc.com/newsroom/press-releases/default__ga-2_135084788_433829689_1639061322-430306379_1633964146.html http://www.tymeinc.com/our-science/mechanism-of-action.html http://www.tymeinc.com/our-science/pipeline.html http://www.tymeinc.com/our-science/scientific-references.html http://www.tymeinc.com/our-science/sm-88-overview.html http://www.tymeinc.com/our-science/sm-88-overview/default__ga-2_124234122_1000831983_1610363728-792361152_1610148064.html http://www.tymeinc.com/our-science/sm-88-overview/default__ga-2_161916092_1000831983_1610363728-792361152_1610148064.html http://www.tymeinc.com/our-science/sm-88-overview/default__ga-2_169359265_1698077543_1594751592-1350588187_1591300768.html http://www.tymeinc.com/our-science/tyme-18-overview.html http://www.tymeinc.com/our-science/tyme-18-overview/default__ga-2_222849048_202045485_1596937705-1350588187_1591300768.html http://www.tymeinc.com/our-science/tyme-19-overview.html http://www.tymeinc.com/our-science/TYME-19-Overview/default.html http://www.tymeinc.com/pipeline/mechanism-of-action/default.html http://www.tymeinc.com/pipeline/pipeline.html http://www.tymeinc.com/pipeline/pipeline/default.html http://www.tymeinc.com/pipeline/scientific-references/default.html http://www.tymeinc.com/privacy-policy-and-terms.html http://www.tymeinc.com/q4api/v3/anticsrf.html http://www.tymeinc.com/sm-88/pipeline.html http://www.tymeinc.com/sm-88/what-is-sm-88.html http://www.tymeinc.com/team/board-of-directors.html http://www.tymeinc.com/tyme-88-panc-popup-iframe/default.html http://www.tymeinc.com/tyme-trials.html http://www.tymeinc.com/tyme-trials/faq.html http://www.tymeinc.com/tyme-trials/patient-support.html http://www.tymeinc.com/ir-sub/events-and-presentations.html http://www.tymeinc.com/ir-sub/investors/investor-overview/default.html http://www.tymeinc.com/ir-sub/node/5821.html http://www.tymeinc.com/team/executives.html http://www.tymeinc.com/news.html http://www.tymeinc.com/investors.html http://www.tymeinc.com/events/ical-1.html http://www.tymeinc.com/ir-sub/index.html http://www.tymeinc.com/science/mechanism-of-action/default.html